4D Molecular Therapeutics

FDMT

NASDAQHealth Care

Income Statement

Total Revenue$37K

Gross Profit$37K

Operating Income$-187.84M

EBITDA$-154.16M

EBIT$-160.87M

Pre-tax Income$-140.11M

Net Income$-160.87M

Cash Equivalent$200.38M

Total Debt$19.32M

Book Value$563.11M

Book Value Per Share11.28

Return on Equity (ROE)-31.51%

Return on Assets (ROA)-28.71%

Return on Invested Capital (ROI)-31.51%

Net Profit Margin-434778.38%

Current Ratio14.92

Quick Ratio14.58

Long-Term Debt / Equitynull